Next Article in Journal
Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
Next Article in Special Issue
Antiproliferative Properties of Type I and Type II Interferon
Previous Article in Journal
Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics
Previous Article in Special Issue
Deregulation of Interferon Signaling in Malignant Cells
Open AccessReview

Lambda Interferons: New Cytokines with Old Functions

Centre for Structural Biology, Department of Molecular Biology, Aarhus University, Aarhus, Denmark
Department of Medical Microbiology and Immunology, Aarhus University, Aarhus, Denmark
Author to whom correspondence should be addressed.
Curent address: Flavivirus-Host Molecular Interactions, Institut Pasteur, Paris, France.
Pharmaceuticals 2010, 3(4), 795-809;
Received: 5 February 2010 / Revised: 24 March 2010 / Accepted: 24 March 2010 / Published: 25 March 2010
(This article belongs to the Special Issue Interferons)
Interferon lambda (IFN-λ) is a member of the class II cytokine family, and like the other members of this family, they are small helical proteins. Since their discovery significant efforts have been made to determine their role in innate and adaptive immunity. Their strong antiviral activity, both in vitro and in vivo, has firmly established their interferon status. However, in contrast to type I interferon, only a very limited subset of cells/tissues responds to interferon lambda. In addition to inducing an antiviral state in responsive cells, recent data suggest that IFN-l plays a role in shaping the adaptive immune response. However, the data is not in complete agreement regarding the effect of IFN-λ on the adaptive immune system. Recently IFN-l has entered clinical trials against hepatitis C Virus and IFN-l is a promising future therapeutic, against different viruses replicating in responsive tissues, like that of the airway epithelia. In this review we describe the knowledge acquired during the past six years about the structure and function of interferon lambda. View Full-Text
Keywords: Interferon; structure; innate immunity; adaptive immunity; antiviral activity; ISGF3; IFN-λR1 Interferon; structure; innate immunity; adaptive immunity; antiviral activity; ISGF3; IFN-λR1
Show Figures

Graphical abstract

MDPI and ACS Style

Hamming, O.J.; Gad, H.H.; Paludan, S.; Hartmann, R. Lambda Interferons: New Cytokines with Old Functions. Pharmaceuticals 2010, 3, 795-809.

AMA Style

Hamming OJ, Gad HH, Paludan S, Hartmann R. Lambda Interferons: New Cytokines with Old Functions. Pharmaceuticals. 2010; 3(4):795-809.

Chicago/Turabian Style

Hamming, Ole J.; Gad, Hans Henrik; Paludan, Søren; Hartmann, Rune. 2010. "Lambda Interferons: New Cytokines with Old Functions" Pharmaceuticals 3, no. 4: 795-809.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop